{"id":40157,"date":"2013-09-19T18:02:24","date_gmt":"2013-09-19T22:02:24","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=40157"},"modified":"2013-09-19T18:20:00","modified_gmt":"2013-09-19T22:20:00","slug":"wisdom","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2013\/09\/19\/wisdom\/","title":{"rendered":"wisdom…"},"content":{"rendered":"\n

It’s a funny thing – getting old. When you read something that’s really wise, you still almost automatically think of the author as older<\/em> and wiser<\/em>, at least I do. I often feel that way when I read Howard Brody’s blog Hooked: Ethics, Medicine, and Pharma<\/font><\/a>. He just seems to be able to step further back from the fray than I can. I feel that same way about Roy Poses of Healthcare Renewal<\/font><\/a>. There’s a $5 word, perspecacious, that covers what I’m talking about. And for all I know, I’m older than both of them. <\/p>\n

Recently, a lot of us have been stirred up by the testimony of Neal Parker, a former FDA lawyer now working for Abbot who spoke on behalf of AbbVie, one of the companies suing the European Medicines Agency to block their proposed data transparency program [see a deal-breaker?…<\/a>, right on the money…<\/a>]. Dr. Poses wrote about my take on things and added some of his usual wisdom [Why Trust Drug Company Executives After One Admits Commercially Sponsored Clinical Research Is All About "Competitive Advantage?"<\/a>]. This week, Dr. Brody also weighed in. This is the part that struck me reading it:<\/div>\n
\n
Science vs. Trade Secrets: Can Pharma Tell the Difference?<\/a><\/div>\n
Hooked: Ethics, Medicine, and Pharma<\/font><\/strong><\/div>\n
by Howard Brody MD<\/div>\n
September 16, 2013<\/div>\n

<\/p>\n

… “1 Boring Old Man” draws two conclusions from this presentation and the ensuing Q&A:<\/div>\n